All News

gout.podagra.jpg

Pegloticase in Severe Refractory Gout

d Olga Petryna, MD

Listen as Dr. Petryna reviews abstracts #0683 (Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Co-treatment of Methotrexate) and #0677 (A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR): 12-Month Results of an Open-Label Study) from the 2020 ACR meeting. 

Read Article
blackboard chalkboard

SpA: Etiology to Diagnosis to Treatment - An Abstract Roundup

d Robert Chao, MD

Here's a review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment.  

Read Article
PROs in Psoriatic Arthritis: Dr. Antoni Chan ( @synovialjoints) reviews abstract #0169 presented at #ACR20. https://t.co/hTlrZMNnab https://t.co/HMOMnT36zf

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @Janetbirdope : Gout has more comorbidities than RA & PsA #1466 Half of respondents are correct @RheumNow @CRASCRRheum #ACR20 https://t.co/T81eo3CGjq

Links:

Dr. John Cush RheumNow ( View Tweet)

Check this out! Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein ( @ejdein1) #ACR20 https://t.co/dAgYOFMMJC https://t.co/QV02h171yP

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @doctorRBC : Gender disparity in Ankylosing Spondylitis symptoms. 1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use 2⃣HLA-B not associated w/ enthesitis @RheumNow #ACR20 Abs#1872 https://t.co/pBcpuqgq0K https://t.co/YWKFUdIgMl

Links:

Dr. John Cush RheumNow ( View Tweet)
"Erosions on X-ray: can we delegate this to the computers?" by Dr. David Liew ( @drdavidliew) #ACR20 https://t.co/YvKjAWebT9 https://t.co/RS4P29UVym

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatoid Arthritis and ILD: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Jeffrey Sparks ( @jeffsparks) about abstracts #0392, #0491, #1198 and #0489 presented at #ACR20. https://t.co/e6HI1SqqSf https://t.co/naXAo8nc1g

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @uptoTate : What a great interview with @IreneBlancoMD regarding equity and inclusion in rheumatology. She is amazing! Such an important topic for all of us! #ACR20 @rheumnow https://t.co/HCnTD8XkAd

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Mrinalini Dey ( @DrMiniDey) interviews Dr. James Galloway on infection in rheumatic diseases, and the studies and presentations he's interested in on infection at #ACR20. https://t.co/5HE7ByhjXo https://t.co/77oLtO2MEQ

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACRO20Tweets "RT @RHEUMarampa : Large cohort of older RA pts newly rx w/HCQ or MTX: 👉~2-fold ⬆ risk of VTE – both PE and DVT- among patients newly treated with MTX vs. HCQ. @RheumNow #ACR20 abs#2000 @DanielHSolomon https://t.co/4gK7hwdhIr" https://t.co/JsGBFrp7Hl

Links:

Dr. John Cush RheumNow ( View Tweet)
Did you know we have podcast? Search Rheum Now on Apple/Android/Soundcloud or listen directly through the link below. https://t.co/wjBWCrKL34 https://t.co/Sin6gVXbeB

Links:

Dr. John Cush RheumNow ( View Tweet)
Miss anything during #ACR20? The RheumNow podcast has got it covered. Catch our podcast on ACR20-Opening Day. https://t.co/dG2H80Qycw https://t.co/EzNl4lm1fB

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @ejdein1 : #ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/knduk3l6xV https://t.co/SNommxn1jA

Links:

Dr. John Cush RheumNow ( View Tweet)
SKIPPAIN Trial: Dr. Sheila Reyes ( @RHEUMarampa) reviews abstract #0899 presented at #ACR20. https://t.co/yoQ8MEH2Br https://t.co/1uRKEp88le

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @ejdein1 : Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA https://t.co/JH07pMjvRe https://t.co/H9LHwiw4xL

Links:

Dr. John Cush RheumNow ( View Tweet)
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952 presented at #ACR20. https://t.co/xeiMYLZEQa https://t.co/a4RJ6BrNgn

Links:

Dr. John Cush RheumNow ( View Tweet)
Vaccination with Shingrix: Does it work for patients on JAKi? #ACR20 https://t.co/PLWn3SshcI https://t.co/APBcfP1zlH

Links:

Dr. John Cush RheumNow ( View Tweet)
Nomenclature, Uveitis and Other Spondyloarthritis Features with Dr. Lianne Gensler #ACR20 https://t.co/zql7iySXOA https://t.co/PY9k108QTc

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @doctorRBC : Tocilizumab NOT effective in preventing mechanical ventilation or death in moderately ill COVID-19 pts. Double-blind, Placebo, RCT (n=243) @RheumNow #ACR20 Abs#L07 #ACRbest https://t.co/Gi5FpodeKf https://t.co/bTk8n7dNni

Links:

Dr. John Cush RheumNow ( View Tweet)
×